ESVS 35th Hybrid Annual Meeting: 28th - 29th September 2021
Abstract Submission for the ESVS 35th Annual Meeting is open!
Why submit an abstract?
- Get a chance to present your research at the meeting of the leading Vascular Society in Europe
- Receive direct feedback from the best experts in vascular care
- Possibility of publication in the EJVES or EJVES Vascular Forum
It's your chance to shine! Don't wait until the last minute. The submission deadline is 1 April 2021.
ESVS e-Library Access
ESVS Membership - What's in it for you?
We asked over 150 individuals from our database which member benefits are the most attractive:
12 month online subscription to the European Journal of Vascular and Endovascular Surgery (EJVES)
What does the EJVES deliver to members?
- Insights for vascular surgeons dealing with patients with arterial, venous and lymphatic diseases
- Diagnosis, investigation and management of these vascular disorders
- Articles describing endovascular method and their critical evaluation and much more
ESVS Academy Pathways Project
View the latest ESVS Newsletters:
February 2021: Headlines
The February 2021 issue is online and features two exciting transatlantic Editorials.
The first Editorial, by Martin Björck and Thomas Huber, offers a Transatlantic Perspective on Chronic Mesenteric Ischaemia (read for free).
The second Editorial, written by Peter Gloviczki, the Editor-in-Chief of our US sister journal JVS, offers a Transatlantic Perspective on the ESVS Practice Guidelines on Venous Thrombosis (read for free), which were published last month (read for free).
Of note, the February issue also features two EJVES Open Access papers.
The first Open Access paper, by Bernhoff et al., investigates National Incidence and Outcome of Popliteal Artery Injury Associated with Knee Trauma (read for free). It found that popliteal artery injuries occur in up to 8% after complex knee dislocations, but only in 0.2% after close to knee fractures. Very importantly: outcome was bad if vascular injury was missed. It comes with an invited commentary by Prendes et al.
The second Open Access paper, by Baderkhan et al., investigates Celiprolol Treatment in Patients with Vascular Ehlers-Danlos Syndrome (read for free). It is reassuring that patients benefit from celiprolol treatment, even though not all fatal vascular events can be prevented. It comes with an invited commentary by Kelly et al.
February 2021: ESVS Educational Travel Grants
Your chance to apply for funding for an educational placement
How to apply:
- Ensure you have an active European ESVS trainee or full membership
- Complete the online application before March 31st, 2021
Bookings are open today!
- 11th March @ 18:00 CET - CVD Patients (Presentation, examination, treatment planning) - Reserve your place
- 18th March @ 18:00 CET - Importance of duplex in Aorto-Iliac disease : Screening to treatment and follow up - Reserve your place
- 25th March @ 18:00 CET - Optimising Medical Treatment for PAD - Reserve your place
- 10th June @ 18:00 CET - FEBVS Exam Preparation (Venous Pathway) - Reserve your place
- 16th September @ 18:00 CET - FEBVS Exam Preparation (Venous Pathway) - Reserve your place
- 9th December @ 18:00 CET - FEBVS Exam Preparation (Aortic Pathway) - Reserve your place
What to expect
Aortic Pathway 2021 (Lead By: Prof. Zoran Rancic)
- Importance of Duplex in Aortic-Iliac Disease
- Planning and Sizing: How to use software
- Planning and Sizing: Elective EVAR
- Planning and Sizing: Emergent EVAR
- Endovascular Toolkit
PAD Pathway 2021 (Lead By: Dr. Igor Koncar)
- Optimising Medical Treatment for Chronic PAD
- Open Surgery Toolkit
- Basic Vascular Anastomosis
- Endovascular Toolkit for PAD
- Best Medical Treatment Postintervention
Venous Pathway 2021 (Lead By: Dr. Adam Zielinski & Dr. Kim Bredahl)
- Patients with CVD - Presentation, Examination, Treatment Planning
- EVLA - How to do it safely and Efficiently
- Patients with CVD - Which method should you choose for treatment
- Deep Vein Stenting
- Venous Ultrasound
The ESVS Academy is preparing a brand new educational offer for 2021
You spoke and the results are in...
We asked over 150 individuals from our database which member benefits are the most attractive: Discount on ESVS Training Courses
ESVS Members are entitled to discounts on all ESVS Educational Training Courses, join ESVS here.
Coming soon! 2021 Academic Pathways:
Kickoff on Thursday 11th March 2021:
Patients with CVD: including LIVE ULTRASOUND broadcast from Bellvitge Hospital, Barcelona
Delivered by: M de Maeseneer (Rotterdam) and E Iborra (Barcelona)
ESVS Membership Benefits
- 12 month online subscription to the European Journal of Vascular and Endovascular Surgery for free. Saving almost 400€
- 12 month print subscription to the EJVES for just 40 Euro. Saving over 400€
- Up to 260€ discount on ESVS Annual Meeting registration fees
- Free online attendance to the ESVS M@sterclass event. Saving up to 100€
- Free access to the NEW ESVS e-library - scientific and educational resources; videos, podcasts, abstract books, online interactive textbook. Saving 500€
- Discounts on ESVS training courses and seminars
- Eligibility for several grant applications
- The chance to vote on important future decisions within the society
- Access to the membership directory
- Regular ESVS society news via the Newsletter
- Even more possible discounts
EJVS & EJVES Vascular Forum - January Headlines
The January 2021 issue is online and features the first ESVS Practice Guidelines on Venous Thrombosis (read for free).
The issue’s opening Editorial presents The current team behind the EJVES and explains the latest changes in the Editorial Staff. We thank and bid good bye to Mark Koelemay, our longstanding Systematic Review Section editor, and welcome Isabelle van Herzeele and Oliver Lyons as incoming associate editors to reinforce the team (read for free).
The second Editorial, by Björck et al., comments on a Hot Topic: the long awaited SWEDEPAD trial that was finally published in the NEJM in December 2020. This first registry based randomised controlled trial within the Swedvasc registry brings some Reassuring clarity to the ‘paclitaxel in peripheral arteries’ controversy! (read for free).
The last Editorial, by J. Earnshaw, initiates a new Debate about the indication for elective abdominal aortic aneurysm repair, claiming that the simplistic 5.5 cm threshold should be revisited after emerging evidence from national population screening programmes and the deferral of elective surgery forced by the Covid pandemic (read this thought provoking perspective for free).
Starting with this issue, we will now be offering three Editor’s choice papers every month, and hope to improve fast dissemination of particularly important findings within the vascular community.
The first Editor’s choice paper are the ESVS 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis (read for free).
The second Editor’s choice paper, by Latz et al., reports Mortality following elective open repair of complex AAA in the US NSQIP database. They observed that 30 day mortality was almost twice that of complex EVAR. However, selection bias may play a role as well (read for free).
The last Editor’s choice paper, by Risum et al., investigates the Effect of statins on mortality after AAA repair in a systematic review involving 70 000 patients. At 3 years statins were associated with a relative mortality reduction by a third! Any questions?
(read for free).